Consistency of ranking was evaluated as new measure for prediction model stability: longitudinal cohort study.


Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
10 2021
Historique:
received: 31 12 2020
revised: 17 06 2021
accepted: 29 06 2021
pubmed: 6 7 2021
medline: 30 11 2021
entrez: 5 7 2021
Statut: ppublish

Résumé

Clinical risk prediction models are generally assessed on population level with a lack of measures that evaluate their stability at predicting risks of individual patients. This study evaluated the use of ranking as a measure to assess individual level stability between risk prediction models. A large patient cohort (3.66 million patients with 0.11 million cardiovascular events) extracted from the Clinical Practice Research Datalink was used in the exemplar of cardiovascular disease risk prediction. It was found that 15 models (including machine learning and statistical models) had similar population-level model performance (C statistics about 0.88). For patients with high absolute risks, the models were more consistent in ranking of risk predictions (interquartile range (IQR) of differences in rank percentiles -0.6 to 1.0), but inconsistent in absolute risk (IQR of differences in absolute risk -18.8 to 9.0). At low risk, the reverse was true with inconsistent ranking but more consistent absolute risk. Consistency of ranking of individual risk predictions is a useful measure to assess risk prediction models providing complementary information to absolute risk stability. Model developing guidelines including "TRIPOD" and "PROBAST" should incorporate ranking to assess individual level stability between risk prediction models.

Identifiants

pubmed: 34224835
pii: S0895-4356(21)00204-3
doi: 10.1016/j.jclinepi.2021.06.026
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

168-177

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Yan Li (Y)

Health e-Research Centre, School of Health Sciences, Faculty of Biology, Medicine and Health, the University of Manchester, Manchester, Oxford Road, Manchester, M13 9PL, UK; School of Mathematical Sciences, Xiamen University, Xiamen, 361005, People's Republic of China.

Matthew Sperrin (M)

Health e-Research Centre, School of Health Sciences, Faculty of Biology, Medicine and Health, the University of Manchester, Manchester, Oxford Road, Manchester, M13 9PL, UK.

Darren M Ashcroft (DM)

Centre for Pharmacoepidemiology and Drug Safety, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Oxford Road, Manchester, M13 9PL, UK; NIHR Greater Manchester Patient Safety Translational Research Centre, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.

Tjeerd Pieter van Staa (TP)

Health e-Research Centre, School of Health Sciences, Faculty of Biology, Medicine and Health, the University of Manchester, Manchester, Oxford Road, Manchester, M13 9PL, UK; NIHR Greater Manchester Patient Safety Translational Research Centre, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Oxford Road, Manchester, M13 9PL, UK. Electronic address: tjeerd.vanstaa@manchester.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH